Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern…
To make it to the winner’s circle in this industry, you must know your strengths and leverage them to maximize every available opportunity. While it’s no secret that Canada cannot compete with patient populations from the U.S. or BRIC (Brazil, Russia, India & China) countries for large scale global trials, when it comes to conducting early phase oncology clinical trials, Canada is a fierce competitor that should never be overlooked.
Canada boasts a group of internationally renowned investigators who are at the forefront of oncology clinical research. Centers of excellence are located in densely populated cities with access to patients from large catchment areas. Many of these centers are highly skilled in early phase work and are very motivated to get involved at the ground level.
In fact, Canada has the only Phase II consortium outside the United States that is sponsored by the National Cancer Institute.
Now imagine if you could get privileged access to sites like these and conduct trials FASTER, BETTER & CHEAPER than you are today.
Check out this informative Quick Reference Guide for tips and strategies on how you can reduce the number of sites you need, accelerate site start-up times by up to 50%, and at the same time enhance your patient recruitment. On top of that, you may also find out that you qualify to save up to 30% on your professional service fees.
If you like what you read about what’s being done to disrupt the status quo and improve the process then please share it with colleagues who you feel would also benefit.
Please let us know what you and your company are doing to stay ahead of the curve and beat competitors to market that may be bigger and better funded than you. It’s time for us all to collaborate and think differently.